The GROWTH consortium, funded by the European Commission (2019-2023), is made up to train a new generation of researchers working on new pathological insights, biomarker diagnostics and personalized nutritional interventions for intestinal failure in neonates and preterm infants.
Academic and industry partners, covering various disciplines ranging from fundamental research to clinical paediatrics and analytical chemistry to organoid and gut-on-chip applications, have teamed up in the European Union.
GROWTH aims to set-up a new European platform that trains young scientists in the industry-led exploration of innovative routes to fully exploit the potential of early life nutrition to prevent inflammatory disease. GROWTH coordinates 8 individual research projects.
If you have any questions you can fill in the form or mail us directly: email@example.com.
Naomi Wieser, GROWTH fellow hosted by DSCN Research BV and Amsterdam UMC and now on secondment at Imperial College London was invited and even received a travel award to prepare an oral presentation at the Digestive Disease Week. Her presentation title was "Human milk and neonatal gut bacterial derived aryl hidrocarban receptor ligands reduce NFkb and chemokine activation in human fetal organoids".
Mon, 23 May